GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Accumulated other comprehensive income (loss)

Proteomics International Laboratories (ASX:PIQ) Accumulated other comprehensive income (loss) : A$1.78 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Proteomics International Laboratories's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was A$1.78 Mil.

Proteomics International Laboratories's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 (A$1.68 Mil) to Jun. 2023 (A$1.83 Mil) but then declined from Jun. 2023 (A$1.83 Mil) to Dec. 2023 (A$1.78 Mil).

Proteomics International Laboratories's annual Accumulated other comprehensive income (loss) increased from Jun. 2021 (A$1.17 Mil) to Jun. 2022 (A$1.68 Mil) and increased from Jun. 2022 (A$1.68 Mil) to Jun. 2023 (A$1.83 Mil).


Proteomics International Laboratories Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Proteomics International Laboratories's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Accumulated other comprehensive income (loss) Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only 0.71 1.05 1.17 1.68 1.83

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.68 1.68 1.83 1.78

Proteomics International Laboratories Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Proteomics International Laboratories Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories (ASX:PIQ) Business Description

Industry
Traded in Other Exchanges
N/A
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines